CONMED Corporation (CNMD)

Currency in USD
36.66
+0.70(+1.95%)
Closed·
37.00+0.34(+0.93%)
·
Unusual trading volume
CNMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
35.3438.86
52 wk Range
33.2161.08
Key Statistics
Prev. Close
36.66
Open
37.04
Day's Range
35.34-38.86
52 wk Range
33.21-61.08
Volume
1.18M
Average Volume (3m)
458.24K
1-Year Change
-35.8979%
Book Value / Share
33.51
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CNMD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
44.75
Upside
+22.07%
Members' Sentiments
Bearish
Bullish
ProTips
4 analysts have revised their earnings upwards for the upcoming period

CONMED Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Analyst Ratings

0 Buy
5 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 44.75
(+22.07% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
JPMorgan
Hold40.00+9.11%43.00Maintain30-04-2026
Piper Sandler
Hold39.00+6.38%55.00Downgrade17-03-2026
Wells Fargo
Hold42.00+14.57%41.00Maintain29-01-2026
Wells Fargo
Hold47.00+28.21%57.00Maintain06-11-2025
Piper Sandler
Buy55.00+50.03%68.00Maintain06-11-2025

CONMED Corporation Earnings Call Summary for Q1/2026

  • CONMED Q1 2026 EPS of $0.89 beat forecasts by 8.54%; revenue reached $317M vs. $310.59M expected, though stock fell 2.26% after hours.
  • Total sales declined 1.3% YoY due to GI product line exit; organic growth positive at 2.1% with orthopedics showing mid-single-digit growth.
  • Adjusted gross margin improved 100 bps to 57.4%; U.S. sales down 5.8% while international sales grew 1.0% in the quarter.
  • Company guides high single to low double-digit growth for AirSeal and Buffalo Filter; full-year operating cash flow target set at $145-155M.
  • CEO emphasizes focus on high-margin products despite GI exit challenges; analysts project full-year EPS of $4.43 with price targets of $39-52.
Last Updated: 30-04-2026, 02:58 am
Read Full Transcript

Earnings

Latest Release
29-04-2026
EPS / Forecast
0.89 / 0.82
Revenue / Forecast
317M / 310.59M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.51%
Dividend Yield
2.17%
Industry Median 1.50%
Annualised payout
0.80
Paid quarterly
5-Years Growth
-5.59%
Growth Streak

CNMD Income Statement

Compare CNMD to Peers and Sector

Metrics to compare
CNMD
Peers
Sector
Relationship
P/E Ratio
20.1x26.2x−0.5x
PEG Ratio
−0.370.310.00
Price/Book
1.1x3.6x2.6x
Price / LTM Sales
0.8x2.7x3.2x
Upside (Analyst Target)
11.2%50.0%48.8%
Fair Value Upside
Unlock33.7%6.9%Unlock

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
16.18M53.69%581.97M
Other Institutional Investors
17.89M46.31%643.48M
Public Companies & Retail Investors
0.000.00%0.00
Total
34.08M100.00%1.23B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.15.84%47,74,4221,71,688
The Vanguard Group, Inc.12.22%36,84,4391,32,492

FAQ

What Is the CONMED (CNMD) Share Price Today?

The CONMED share price today is 36.66.

What is the current CONMED (CNMD) share price and day range?

As of 01-05-2026, the CONMED share price is 36.66, with a previous close of 36.66. The share price has ranged from 35.34 to 38.86 today, while the 52-week range spans from 33.21 to 61.08.

What Is the CONMED Market Cap?

As of today, CONMED market cap is 1.11B.

Does CONMED Pay Dividends? What's The Current Dividend Yield?

The CONMED dividend yield is 2.17%.

What Is the CONMED (CNMD) Share Price Target?

The average 12-month share price target for CONMED is 44.75, with a high estimate of 52 and a low estimate of 39. 0 analysts recommend buying, while 0 suggest selling, with an overall rating of Neutral and +22.07% Upside potential.

What Is CONMED's Earnings Per Share (TTM)?

The CONMED EPS (TTM) is 1.51.

When Is the Next CONMED Earnings Date?

CONMED will release its next earnings report on 29-07-2026.

From a Technical Analysis Perspective, Is CNMD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does CONMED Trade On?

CONMED is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for CONMED?

The stock symbol for CONMED is "CNMD."

How Many Times Has CONMED Stock Split?

CONMED has split 3 times.

How Many Employees Does CONMED Have?

CONMED has 3900 employees.

What Is the CNMD Premarket Price?

CNMD's last pre-market stock price is 37.05. The pre-market share volume is 210.00, and the stock has changed by 1.09, or 3.03%.

What Is the CNMD After Hours Price?

CNMD's last after hours stock price is 37.00, the stock has changed by 0.34, or 0.93%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.